Add like
Add dislike
Add to saved papers

The effect of adding nanoparticles to dental porcelain on the fracture resistance and bond strength to zirconia core.

Background: Porcelain combined with zirconia core substructure has low fracture toughness. Nanoparticles are incorporated into the porcelain to boost its mechanical properties.

Aims: To evaluate the effect of the incorporation of silver oxide and titanium oxide nanoparticles into porcelain powder on the bond strength of porcelain veneer to zirconia core. The flexural strength of nanoparticles-modified porcelain was also evaluated.

Materials and Methods: The flexural strength of feldspathic porcelain was measured (according to ISO specifications number 6872) after the incorporation of silver and titanium oxide nanoparticles. For measuring the bond strength at the porcelain-zirconia interface, 70 bars (4 × 4 × 12 mm) of zirconia were cut and fired in a furnace. The control and nanoparticles-modified porcelain powders were built up on the zirconia bars and fired to create veneers of 3 mm height, 4 mm width and 4 mm thickness. The porcelain veneers were de-attached from the zirconia core by the universal testing machine. The failure load was recorded to calculate the bond strength.

Statistical Analysis: The data were analysed with one-way analysis of variance followed by Tukey's test.

Results: The addition of 0.5-1.5% silver oxide nanoparticles to feldspathic porcelain increased the flexural strength. The addition of 1.0-4.0% titanium oxide nanoparticles to feldspathic porcelain increased the flexural strength. Either 0.5-1.0% silver oxide or 3.0-4.0% titanium oxide nanoparticles in feldspathic porcelain increased the shear bond strength to zirconia core.

Conclusion: The flexural strength of porcelain veneer and the bond strength at porcelain-zirconia interface can be improved by adding either 0.5% silver oxide nanoparticles or 4% titanium oxide nanoparticles to porcelain powder.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app